Skip to content
Original
mp.weixin.qq.com·· 2 days agoScore60

Youkadi Publishes Case Report of U87 Injection in Refractory INI-1/BRM-Deficient Sinonasal Cancer

In brief

Youkadi and the Eye and ENT Hospital of Fudan University have published a case report of U87 injection treating refractory INI-1/BRM-deficient sinonasal cancer in Molecular Therapy Oncology. The patient's tumor showed Trop2-positive expression, had prior multiple lines of therapy, and imaging on day 78 showed tumor response.

Source: mp.weixin.qq.com · mp.weixin.qq.com

#Clinical readout#Cell therapy#Oncology#Biomarkers
CBACBA Frontier Insights (CFI)Chinese Biopharmaceutical Association (CBA)www.cba-usa.org

Disclaimer CBA Frontier Insights uses AI-assisted methods to aggregate, summarize, and analyze publicly accessible biopharmaceutical information. Content is provided for informational and educational purposes only and does not represent the official views of original sources or affiliated organizations. AI-generated content may contain errors; please verify important information against primary sources. Intellectual property rights remain with their respective owners. For copyright concerns or corrections, please contact us through the website’s feedback page.